Cargando…
Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Genetic, biochemical, and anatomical grounds led to the proposal of the amyloid cascade hypothesis centered on the accumulation of amyloid beta peptides (Aβ) to explain Alzheimer's disease (AD) etiology. In this context, a bulk of efforts have aimed at developing therapeutic strategies seeking...
Autores principales: | Checler, Frédéric, Afram, Elissa, Pardossi-Piquard, Raphaëlle, Lauritzen, Inger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027268/ https://www.ncbi.nlm.nih.gov/pubmed/33662398 http://dx.doi.org/10.1016/j.jbc.2021.100489 |
Ejemplares similares
-
The beta-secretase-derived C-terminal fragment of APP (C99): a key determinant for intraneuronal pathology in the 3xTgAD mouse
por: Lauritzen, Inger, et al.
Publicado: (2013) -
The η-secretase-derived APP fragment ηCTF is localized in Golgi, endosomes and extracellular vesicles and contributes to Aβ production
por: Afram, Elissa, et al.
Publicado: (2023) -
The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse Alzheimer’s Disease Models
por: Bécot, Anaïs, et al.
Publicado: (2020) -
Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology
por: Lauritzen, Inger, et al.
Publicado: (2016) -
Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models
por: Lauritzen, Inger, et al.
Publicado: (2019)